These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6343299)

  • 1. [Treatment of subacute cutaneous lupus erythematosus with thalidomide].
    Volc-Platzer B; Wolff K
    Hautarzt; 1983 Apr; 34(4):175-8. PubMed ID: 6343299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoprotection by thalidomide in patients with chronic cutaneous and systemic lupus erythematosus: discordant effects on minimal erythema dose and sunburn cell formation.
    Cummins DL; Gaspari AA
    Br J Dermatol; 2004 Aug; 151(2):458-64. PubMed ID: 15327555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW; Sontheimer RD
    Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thalidomide in the treatment of chronic lupus erythematosus].
    Scolari F; Harms M; Gilardi S
    Dermatologica; 1982 Oct; 165(4):355-62. PubMed ID: 7152071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thalidomide therapy of cutaneous lupus erythematosus].
    Bohmeyer J; Achenbach A; Westenberger M; Stadler R
    Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of immunomorphological study of the skin in differential diagnosis of systemic lupus erythematosus].
    Tareeva IE; Serov VV; Borisov IA; Varshavskiĭ VA; Kakturskiĭ LV
    Klin Med (Mosk); 1973 Jul; 51(7):110-3. PubMed ID: 4594892
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thalidomide and thrombosis].
    Flageul B; Wallach D; Cavelier-Balloy B; Bachelez H; Carsuzaa F; Dubertret L
    Ann Dermatol Venereol; 2000 Feb; 127(2):171-4. PubMed ID: 10739975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus with multiple myeloma.
    Pehamberger H; Diem E; Konrad K
    Acta Derm Venereol; 1978; 58(6):527-30. PubMed ID: 83077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo nuclear localization of immunoglobulins in clinically normal skin in systemic and procainamide-induced lupus erythematosus.
    de la Baart Faille-Kuyper EH
    Neth J Med; 1974; 17(2):58-65. PubMed ID: 4599538
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chilblain lupus erythematosus. A case report].
    Brado B; Keilholz U; Tilgen W; Pezzutto A; Gissler M; Hunstein W
    Internist (Berl); 1992 Oct; 33(10):701-3. PubMed ID: 1428687
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of generalized discoid skin lesions with azathioprine. Its use in a patient with systemic lupus erythematosus.
    Tsokos GC; Caughman SW; Klippel JH
    Arch Dermatol; 1985 Oct; 121(10):1323-5. PubMed ID: 4037829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative histological, histo-immunological and ultrastructural study of healthy and pathological skin in acute disseminated lupus erythematosus and chronic lupus erythematosus].
    Lambert D; Justrabo E; Perrot H; Schmitt D; Cabanne F; Chapuis JL; Michiels R; Thivolet J
    Ann Anat Pathol (Paris); 1973; 18(4):419-36. PubMed ID: 4601805
    [No Abstract]   [Full Text] [Related]  

  • 13. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.
    Cuadrado MJ; Karim Y; Sanna G; Smith E; Khamashta MA; Hughes GR
    Am J Med; 2005 Mar; 118(3):246-50. PubMed ID: 15745722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological and immunohistochemical changes in the kidneys and skin in systemic lupus erythematosus during the course of treatment].
    Gritsman NN; Akhnazarova VD; Ivanova MM; Solov'ev SK
    Revmatologiia (Mosk); 1983; (2):41-5. PubMed ID: 6353514
    [No Abstract]   [Full Text] [Related]  

  • 15. Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis.
    Mori Y; Kishimoto N; Yamahara H; Kijima Y; Nose A; Uchiyama-Tanaka Y; Fukui M; Kitamura T; Tokoro T; Masaki H; Nagata T; Umeda Y; Nishikawa M; Iwasaka T
    Clin Exp Nephrol; 2005 Mar; 9(1):79-84. PubMed ID: 15830279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide treatment for hypertrophic cutaneous lupus erythematosus.
    Gambini D; Carrera C; Passoni E; Muratori S; Berti E; Caputo R
    J Dermatolog Treat; 2004 Dec; 15(6):365-71. PubMed ID: 15764048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic lupus erythematosus with bullous manifestations. Association with bullous pemphigoid and a rare presentation of systemic lupus erythematosus].
    Bittencourt AL; Brito E; Sadigursky M; Dias NF
    Acta Med Port; 1984; 5(4-5):119-25. PubMed ID: 6380218
    [No Abstract]   [Full Text] [Related]  

  • 18. Variability of the lupus band test. Results in 18 patients with systemic lupus erythematosus.
    Jacobs MI; Schned ES; Bystryn JC
    Arch Dermatol; 1983 Nov; 119(11):883-9. PubMed ID: 6357104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin M predominance in cutaneous lupus erythematosus.
    Kontos AP; Jirsari M; Jacobsen G; Fivenson DP
    J Cutan Pathol; 2005 May; 32(5):352-5. PubMed ID: 15811120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunomorphological changes in the skin of patients with systemic lupus erythematosus and the effect of cytostatic therapy].
    Solov'ev SK; Akhnazarova VD; Ivanova MM
    Ter Arkh; 1981; 53(7):33-6. PubMed ID: 7027510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.